Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David I Watkins

Showing results (31-40 of 163) with videos related to

Pageof 17
Sort By:
Plos One|January 6, 2009
Localized populations of CD8 MHC class I tetramer SIV-specific T cells in lymphoid follicles and genital epitheliumJung Joo Hong, Matthew R Reynolds, Teresa L Mattila, et al.
Journal of Virology|March 3, 2004
Repeated low-dose mucosal simian immunodeficiency virus SIVmac239 challenge results in the same viral and immunological kinetics as high-dose challenge: a model for the evaluation of vaccine efficacy in nonhuman primatesAdrian B McDermott, Jacque Mitchen, Shari Piaskowski, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 24, 2005
Rhesus macaque MHC class I molecules present HLA-B-like peptidesHeather D Hickman-Miller, Wilfried Bardet, Angela Gilb, et al.
Journal of Virology|January 29, 2003
Expression of the major histocompatibility complex class I molecule Mamu-A*01 is associated with control of simian immunodeficiency virus SIVmac239 replicationBianca R Mothé, Jason Weinfurter, Chenxi Wang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 6, 2012
Escape from CD8(+) T cell responses in Mamu-B*00801(+) macaques differentiates progressors from elite controllersPhilip A Mudd, Adam J Ericsen, Benjamin J Burwitz, et al.
Immunogenetics|June 1, 2011
Chinese origin rhesus macaque major histocompatibility complex class I molecules promiscuously present epitopes from SIV associated with molecules of Indian origin; implications for immunodominance and viral escapeNicholas James Maness, Andrew D Walsh, Richard A Rudersdorf, et al.
Journal of Virology|February 19, 2010
T-cell correlates of vaccine efficacy after a heterologous simian immunodeficiency virus challengeMauricio A Martins, Nancy A Wilson, Jason S Reed, et al.
Frontiers in Immunology|September 14, 2020
Rhesus Cytomegalovirus-Specific CD8<sup>+</sup> Cytotoxic T Lymphocytes Do Not Become Functionally Exhausted in Chronic SIVmac239 InfectionBrandon C Rosen, Nuria Pedreño-Lopez, Michael J Ricciardi, et al.
Immunogenetics|March 5, 2005
Characterization of the peptide-binding specificity of Mamu-A*11 results in the identification of SIV-derived epitopes and interspecies cross-reactivityAlessandro Sette, John Sidney, Huynh-Hoa Bui, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 1, 2022
Env-independent protection of intrarectal SIV challenge by vaccine induction of Gag/Vif-specific CD8<sup>+</sup> T cells but not CD4<sup>+</sup> T cellsHiroshi Ishii, Kazutaka Terahara, Takushi Nomura, et al.
Pageof 17

Showing results (31-40 of 163) with videos related to

Sort By:
Pageof 17
Plos One|January 6, 2009
Localized populations of CD8 MHC class I tetramer SIV-specific T cells in lymphoid follicles and genital epitheliumJung Joo Hong, Matthew R Reynolds, Teresa L Mattila, et al.
Journal of Virology|March 3, 2004
Repeated low-dose mucosal simian immunodeficiency virus SIVmac239 challenge results in the same viral and immunological kinetics as high-dose challenge: a model for the evaluation of vaccine efficacy in nonhuman primatesAdrian B McDermott, Jacque Mitchen, Shari Piaskowski, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 24, 2005
Rhesus macaque MHC class I molecules present HLA-B-like peptidesHeather D Hickman-Miller, Wilfried Bardet, Angela Gilb, et al.
Journal of Virology|January 29, 2003
Expression of the major histocompatibility complex class I molecule Mamu-A*01 is associated with control of simian immunodeficiency virus SIVmac239 replicationBianca R Mothé, Jason Weinfurter, Chenxi Wang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 6, 2012
Escape from CD8(+) T cell responses in Mamu-B*00801(+) macaques differentiates progressors from elite controllersPhilip A Mudd, Adam J Ericsen, Benjamin J Burwitz, et al.
Immunogenetics|June 1, 2011
Chinese origin rhesus macaque major histocompatibility complex class I molecules promiscuously present epitopes from SIV associated with molecules of Indian origin; implications for immunodominance and viral escapeNicholas James Maness, Andrew D Walsh, Richard A Rudersdorf, et al.
Journal of Virology|February 19, 2010
T-cell correlates of vaccine efficacy after a heterologous simian immunodeficiency virus challengeMauricio A Martins, Nancy A Wilson, Jason S Reed, et al.
Frontiers in Immunology|September 14, 2020
Rhesus Cytomegalovirus-Specific CD8<sup>+</sup> Cytotoxic T Lymphocytes Do Not Become Functionally Exhausted in Chronic SIVmac239 InfectionBrandon C Rosen, Nuria Pedreño-Lopez, Michael J Ricciardi, et al.
Immunogenetics|March 5, 2005
Characterization of the peptide-binding specificity of Mamu-A*11 results in the identification of SIV-derived epitopes and interspecies cross-reactivityAlessandro Sette, John Sidney, Huynh-Hoa Bui, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 1, 2022
Env-independent protection of intrarectal SIV challenge by vaccine induction of Gag/Vif-specific CD8<sup>+</sup> T cells but not CD4<sup>+</sup> T cellsHiroshi Ishii, Kazutaka Terahara, Takushi Nomura, et al.
Pageof 17